New perspectives in cancer immunotherapy: targeting IL-6 cytokine family

New perspectives in cancer immunotherapy: targeting IL-6 cytokine family

Chronic inflammation has been recognized as a canonical cancer hallmark. It is orchestrated by cytokines, which are master regulators of the tumor microenvironment (TME) as they represent the main communication bridge between cancer cells, the tumor stroma, and the immune system. Interleukin (IL)-6...

Full description

Bibliographic Details
Main Authors:	Maria Florencia Soler, Andrea Abaurrea, Peio Azcoaga, Angela M Araujo, Maria M Caffarel
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/11/11/e007530.full

Similar Items

The Role of the IL-6 Cytokine Family in Epithelial–Mesenchymal Plasticity in Cancer Progression
by: Andrea Abaurrea, et al.
Published: (2021-08-01)

IL-12 Family Cytokines in Cancer and Immunotherapy
by: Bhalchandra Mirlekar, et al.
Published: (2021-01-01)

Diffuse large B-cell lymphoma microenvironment displays a predominant macrophage infiltrate marked by a strong inflammatory signature
by: Leyre Serna, et al.
Published: (2023-05-01)

IL-6 Cytokine Family: A Putative Target for Breast Cancer Prevention and Treatment
by: Carla M. Felcher, et al.
Published: (2022-02-01)

Role of IL-6 family cytokines in organ fibrosis
by: Ying Chen, et al.
Published: (2023-03-01)

Coordination of Immune-Stroma Crosstalk by IL-6 Family Cytokines
by: Nathaniel R. West
Published: (2019-05-01)

Nonspecific Inhibition of IL6 Family Cytokine Signalling by Soluble gp130
by: Anissa A. Widjaja, et al.
Published: (2024-01-01)

The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer
by: Carlos Martínez-Pérez, et al.
Published: (2021-10-01)

Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
by: Angela M. Araujo, et al.
Published: (2022-09-01)

Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
by: Angela M. Araujo, et al.
Published: (2022-04-01)

The IL-20 cytokine family in rheumatoid arthritis and spondyloarthritis
by: Kragstrup, T, et al.
Published: (2018)

IL-17 and related cytokines involved in systemic sclerosis: Perspectives
by: Rafaela Silva Guimarães Gonçalves, et al.
Published: (2018-01-01)

Engineering cytokine immunotherapies via cell surface targeting
by: Santollani, Luciano
Published: (2024)

Pleiotropic, Unique and Shared Responses Elicited by IL-6 Family Cytokines in Human Vascular Endothelial Cells
by: Madelene Lindkvist, et al.
Published: (2022-01-01)

The application of Interleukin-2 family cytokines in tumor immunotherapy research
by: Yangyihua Zhou, et al.
Published: (2023-03-01)

Editorial: Cytokine and cytokine receptor-based immunotherapies: Updates, controversies, challenges, and future perspectives
by: Jun Wang, et al.
Published: (2022-07-01)

LP-089 Role of inflammatory cytokines, IL-6 and the correlation with ratio of IL-6 and IL-17 serum cytokines in active systemic lupus erythematosus patients
by: Dwitya Elvira
Published: (2023-07-01)

Targeting the IL-9 pathway in cancer immunotherapy
by: Ningbo Zheng, et al.
Published: (2020-10-01)

Cytokines in Cancer Immunotherapy
by: Sylvia Lee, et al.
Published: (2011-10-01)

IL-6–targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function
by: Cate Speake, et al.
Published: (2022-11-01)

ROLE OF IL-4, IL-6, IL-8, IL-10 CYTOKINES IN THE IMMUNOPATHOGENESIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. Yu. Trushina, et al.
Published: (2019-01-01)

Proinflammatory cytokines VEGFA, IL-6, IL-8 as markers of hepatotoxicity after COVID-19
by: M. A. Urevskii, et al.
Published: (2023-06-01)

Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy
by: Yuan Song, et al.
Published: (2022-06-01)

Diagnostic and Prognostic Potential of Exosomal Cytokines IL-6 and IL-10 in Polytrauma Patients
by: Birte Weber, et al.
Published: (2023-07-01)

Targeting IL-12 family cytokines: A potential strategy for type 1 and type 2 diabetes mellitus
by: Jiayu Luo, et al.
Published: (2024-01-01)

Cytokine Based Immunotherapy for Cancer and Lymphoma: Biology, Challenges and Future Perspectives
by: Suheil Albert Atallah-Yunes, et al.
Published: (2022-04-01)

Expression analysis of cytokines IL-5, IL-6, IL-8, IL-17 and VEGF in breast cancer patients
by: Gang Liu, et al.
Published: (2022-12-01)

Serum Levels of Selected IL-1 Family Cytokines in Patients with Morphea
by: Paulina Szczepanik-Kułak, et al.
Published: (2022-10-01)

Th17-Inducing Cytokines IL-6 and IL-23 Are Crucial for Granuloma Formation during Experimental Paracoccidioidomycosis
by: Fabrine Sales Massafera Tristão, et al.
Published: (2017-08-01)

IL-1 family cytokines and their inhibitory proteins in normal pregnancy and pre-eclampsia
by: Southcombe, J, et al.
Published: (2014)

Activation and regulation of IL-1β family of cytokines by EV71 infection
by: Aw, Ashley Jong Ghut
Published: (2014)

Some Cytokines Levels (IL-6 and IL-10) in Sera Patients with Cutaneous Leismanasis in Nassiriya Province
by: Alaa Hussein Oleiwi
Published: (2020-12-01)

Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis
by: Chen XW, et al.
Published: (2015-06-01)

Improving methods for cytokine immunotherapy of cancer
by: Tzeng, Alice
Published: (2016)

Systems Biology and Cytokines Potential Role in Lung Cancer Immunotherapy Targeting Autophagic Axis
by: Riya Khilwani, et al.
Published: (2023-10-01)

Targeting the A3 adenosine receptor to treat cytokine release syndrome in cancer immunotherapy
by: Cohen S, et al.
Published: (2019-01-01)

Longitudinal comparison of IL-6, IL-10, and IL-12 cytokine profiles in adult and childhood-onset systemic lupus erythematosus
by: Karina de Oliveira Peliçari, et al.
Published: (2022-01-01)

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
by: Spranger, Stefani
Published: (2020)

Biosensing Cytokine IL-6: A Comparative Analysis of Natural and Synthetic Receptors
by: Eleonora Alfinito, et al.
Published: (2020-08-01)

Targeting HDAC6 improves anti-CD47 immunotherapy
by: Maria Gracia-Hernandez, et al.
Published: (2024-02-01)